Innate sensors of pathogen and stress: Linking inflammation to obesity

Journal of Allergy and Clinical Immunology

Volumn 132, Issue 2, 2013, Pages 287-294

  Jin, Chengcheng ^a   Flavell, Richard A ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

metabolic inflammation; microbiota; obesity; Pattern recognition receptor

Indexed keywords

ABSENT IN MELANOMA 2 LIKE RECEPTOR; C TYPE LECTIN RECEPTOR; CASPASE RECRUITMENT DOMAIN PROTEIN 15; CASPASE RECRUITMENT DOMAIN PROTEIN 4; CRYOPYRIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INFLAMMASOME; LECTIN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN PROTEIN; NUCLEOTIDE OLIGOMERIZATION DOMAIN CONTAINING PROTEIN; PATTERN RECOGNITION RECEPTOR; PROTEIN NLRC4; PROTEIN NLRP1; PROTEIN NLRP6; RETINOIC ACID INDUCIBLE PROTEIN I; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 11; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ATHEROSCLEROSIS; BRAIN; CELL INFILTRATION; CYTOKINE PRODUCTION; DIABETES MELLITUS; DIETARY INTAKE; DISORDERS OF LIPID METABOLISM; ENCEPHALITIS; GLUCOSE METABOLISM; HUMAN; IMMUNOCOMPETENT CELL; INFLAMMATION; INNATE IMMUNITY; INSULIN RESISTANCE; INTESTINE FLORA; LIVER; METABOLIC DISORDER; METABOLIC STRESS; MUSCLE; NONHUMAN; OBESITY; PANCREAS ISLET; PANCREATITIS; PRIORITY JOURNAL; REVIEW; SENSOR; STRESS; VASCULITIS;

EID: 84881192566     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2013.06.022     Document Type: Article

References (111)

1. M.F. Gregor, and G.S. Hotamisligil Inflammatory mechanisms in obesity Annu Rev Immunol 29 2011 415 445
2. S.T. Weiss Obesity: insight into the origins of asthma Nat Immunol 6 2005 537 539
3. R. Medzhitov Toll-like receptors and innate immunity Nat Rev Immunol 1 2001 135 145
4. O. Takeuchi, and S. Akira Pattern recognition receptors and inflammation Cell 140 2010 805 820
5. T. Kawai, and S. Akira The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors Nat Immunol 11 2010 373 384
6. W. Kanczkowski, C.G. Ziegler, K. Zacharowski, and S.R. Bornstein Toll-like receptors in endocrine disease and diabetes Neuroimmunomodulation 15 2008 54 60
7. M. Fresno, R. Alvarez, and N. Cuesta Toll-like receptors, inflammation, metabolism and obesity Arch Physiol Biochem 117 2011 151 164
8. A.C. Konner, and J.C. Bruning Toll-like receptors: linking inflammation to metabolism Trends Endocrinol Metab 22 2011 16 23
9. P.D. Cani, R. Bibiloni, C. Knauf, A. Waget, A.M. Neyrinck, and N.M. Delzenne Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice Diabetes 57 2008 1470 1481
10. J. Amar, C. Chabo, A. Waget, P. Klopp, C. Vachoux, and L.G. Bermudez-Humaran Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment EMBO Mol Med 3 2011 559 572
11. J.E. Davis, N.K. Gabler, J. Walker-Daniels, and M.E. Spurlock Tlr-4 deficiency selectively protects against obesity induced by diets high in saturated fat Obesity (Silver Spring) 16 2008 1248 1255
12. C. Erridge, and N.J. Samani Saturated fatty acids do not directly stimulate Toll-like receptor signaling Arterioscler Thromb Vasc Biol 29 2009 1944 1949
13. D. Pal, S. Dasgupta, R. Kundu, S. Maitra, G. Das, and S. Mukhopadhyay Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance Nat Med 2012 [Epub ahead of print]
14. L. Li, L. Chen, L. Hu, Y. Liu, H.Y. Sun, and J. Tang Nuclear factor high-mobility group box1 mediating the activation of Toll-like receptor 4 signaling in hepatocytes in the early stage of nonalcoholic fatty liver disease in mice Hepatology 54 2011 1620 1630
15. H. Fischer, P. Ellstrom, K. Ekstrom, L. Gustafsson, M. Gustafsson, and C. Svanborg Ceramide as a TLR4 agonist; a putative signalling intermediate between sphingolipid receptors for microbial ligands and TLR4 Cell Microbiol 9 2007 1239 1251
16. W.L. Holland, B.T. Bikman, L.P. Wang, G. Yuguang, K.M. Sargent, and S. Bulchand Lipid-induced insulin resistance mediated by the proinflammatory receptor TLR4 requires saturated fatty acid-induced ceramide biosynthesis in mice J Clin Invest 121 2011 1858 1870
17. M.R. Dasu, S. Devaraj, S. Park, and I. Jialal Increased toll-like receptor (TLR) activation and TLR ligands in recently diagnosed type 2 diabetic subjects Diabetes Care 33 2010 861 868
18. T.B. Clarke, K.M. Davis, E.S. Lysenko, A.Y. Zhou, Y. Yu, and J.N. Weiser Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innate immunity Nat Med 16 2010 228 231
19. K. Schroder, and J. Tschopp The inflammasomes Cell 140 2010 821 832
20. T. Strowig, J. Henao-Mejia, E. Elinav, and R. Flavell Inflammasomes in health and disease Nature 481 2012 278 286
21. H.M. Lee, J.J. Kim, H.J. Kim, M. Shong, B.J. Ku, and E.K. Jo Upregulated NLRP3 inflammasome activation in patients with type 2 diabetes Diabetes 62 2013 194 204
22. R. Zhou, A. Tardivel, B. Thorens, I. Choi, and J. Tschopp Thioredoxin-interacting protein links oxidative stress to inflammasome activation Nat Immunol 11 2010 136 140
23. H. Wen, D. Gris, Y. Lei, S. Jha, L. Zhang, and M.T. Huang Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling Nat Immunol 12 2011 408 415
24. J.F. Tanti, F. Ceppo, J. Jager, and F. Berthou Implication of inflammatory signaling pathways in obesity-induced insulin resistance Front Endocrinol (Lausanne) 3 2012 181
25. H. Shi, M.V. Kokoeva, K. Inouye, I. Tzameli, H. Yin, and J.S. Flier TLR4 links innate immunity and fatty acid-induced insulin resistance J Clin Invest 116 2006 3015 3025
26. D.M. Tsukumo, M.A. Carvalho-Filho, J.B. Carvalheira, P.O. Prada, S.M. Hirabara, and A.A. Schenka Loss-of-function mutation in Toll-like receptor 4 prevents diet-induced obesity and insulin resistance Diabetes 56 2007 1986 1998
27. T. Suganami, T. Mieda, M. Itoh, Y. Shimoda, Y. Kamei, and Y. Ogawa Attenuation of obesity-induced adipose tissue inflammation in C3H/HeJ mice carrying a Toll-like receptor 4 mutation Biochem Biophys Res Commun 354 2007 45 49
28. M. Poggi, D. Bastelica, P. Gual, M.A. Iglesias, T. Gremeaux, and C. Knauf C3H/HeJ mice carrying a toll-like receptor 4 mutation are protected against the development of insulin resistance in white adipose tissue in response to a high-fat diet Diabetologia 50 2007 1267 1276
29. M. Saberi, N.B. Woods, C. de Luca, S. Schenk, J.C. Lu, and G. Bandyopadhyay Hematopoietic cell-specific deletion of toll-like receptor 4 ameliorates hepatic and adipose tissue insulin resistance in high-fat-fed mice Cell Metab 10 2009 419 429
30. J.S. Orr, M.J. Puglisi, K.L. Ellacott, C.N. Lumeng, D.H. Wasserman, and A.H. Hasty Toll-like receptor 4 deficiency promotes the alternative activation of adipose tissue macrophages Diabetes 61 2012 2718 2727
31. M.S. Radin, S. Sinha, B.A. Bhatt, N. Dedousis, and R.M. O'Doherty Inhibition or deletion of the lipopolysaccharide receptor Toll-like receptor-4 confers partial protection against lipid-induced insulin resistance in rodent skeletal muscle Diabetologia 51 2008 336 346
32. C.A. Rivera, P. Adegboyega, N. van Rooijen, A. Tagalicud, M. Allman, and M. Wallace Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis J Hepatol 47 2007 571 579
33. A. Spruss, G. Kanuri, S. Wagnerberger, S. Haub, S.C. Bischoff, and I. Bergheim Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice Hepatology 50 2009 1094 1104
34. P.D. Cani, J. Amar, M.A. Iglesias, M. Poggi, C. Knauf, and D. Bastelica Metabolic endotoxemia initiates obesity and insulin resistance Diabetes 56 2007 1761 1772
35. C. Erridge Diet, commensals and the intestine as sources of pathogen-associated molecular patterns in atherosclerosis, type 2 diabetes and non-alcoholic fatty liver disease Atherosclerosis 216 2011 1 6
36. F. Kim, M. Pham, I. Luttrell, D.D. Bannerman, J. Tupper, and J. Thaler Toll-like receptor-4 mediates vascular inflammation and insulin resistance in diet-induced obesity Circ Res 100 2007 1589 1596
37. J.J. Senn Toll-like receptor-2 is essential for the development of palmitate-induced insulin resistance in myotubes J Biol Chem 281 2006 26865 26875
38. M.T. Nguyen, S. Favelyukis, A.K. Nguyen, D. Reichart, P.A. Scott, and A. Jenn A subpopulation of macrophages infiltrates hypertrophic adipose tissue and is activated by free fatty acids via Toll-like receptors 2 and 4 and JNK-dependent pathways J Biol Chem 282 2007 35279 35292
39. R.W. Himes, and C.W. Smith Tlr2 is critical for diet-induced metabolic syndrome in a murine model FASEB J 24 2010 731 739
40. J.A. Ehses, D.T. Meier, S. Wueest, J. Rytka, S. Boller, and P.Y. Wielinga Toll-like receptor 2-deficient mice are protected from insulin resistance and beta cell dysfunction induced by a high-fat diet Diabetologia 53 2010 1795 1806
41. L.H. Kuo, P.J. Tsai, M.J. Jiang, Y.L. Chuang, L. Yu, and K.T. Lai Toll-like receptor 2 deficiency improves insulin sensitivity and hepatic insulin signalling in the mouse Diabetologia 54 2011 168 179
42. J.E. Davis, D.R. Braucher, J. Walker-Daniels, and M.E. Spurlock Absence of Tlr2 protects against high-fat diet-induced inflammation and results in greater insulin-stimulated glucose transport in cultured adipocytes J Nutr Biochem 22 2011 136 141
43. A.M. Caricilli, P.H. Nascimento, J.R. Pauli, D.M. Tsukumo, L.A. Velloso, and J.B. Carvalheira Inhibition of toll-like receptor 2 expression improves insulin sensitivity and signaling in muscle and white adipose tissue of mice fed a high-fat diet J Endocrinol 199 2008 399 406
44. K. Miura, Y. Kodama, S. Inokuchi, B. Schnabl, T. Aoyama, and H. Ohnishi Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1beta in mice Gastroenterology 139 2010 323 334.e7
45. J. Henao-Mejia, E. Elinav, C. Jin, L. Hao, W.Z. Mehal, and T. Strowig Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity Nature 482 2012 179 185
46. L. Zhao, P. Hu, Y. Zhou, J. Purohit, and D. Hwang NOD1 activation induces proinflammatory gene expression and insulin resistance in 3T3-L1 adipocytes Am J Physiol Endocrinol Metab 301 2011 E587 E598
47. A.K. Tamrakar, J.D. Schertzer, T.T. Chiu, K.P. Foley, P.J. Bilan, and D.J. Philpott NOD2 activation induces muscle cell-autonomous innate immune responses and insulin resistance Endocrinology 151 2010 5624 5637
48. J. Purohit, P. Hu, S.J. Burke, J.J. Collier, J. Chen, and L. Zhao The effects of NOD activation on adipocyte differentiation Obesity (Silver Spring) 2012 [Epub ahead of print]
49. J.D. Schertzer, A.K. Tamrakar, J.G. Magalhaes, S. Pereira, P.J. Bilan, and M.D. Fullerton NOD1 activators link innate immunity to insulin resistance Diabetes 60 2011 2206 2215
50. B. Vandanmagsar, Y.H. Youm, A. Ravussin, J.E. Galgani, K. Stadler, and R.L. Mynatt The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance Nat Med 17 2011 179 188
51. L.J. Dixon, C.A. Flask, B.G. Papouchado, A.E. Feldstein, and L.E. Nagy Caspase-1 as a central regulator of high fat diet-induced non-alcoholic steatohepatitis PLoS One 8 2013 e56100
52. R. Stienstra, L.A. Joosten, T. Koenen, B. van Tits, J.A. van Diepen, and S.A. van den Berg The inflammasome-mediated caspase-1 activation controls adipocyte differentiation and insulin sensitivity Cell Metab 12 2010 593 605
53. R. Stienstra, J.A. van Diepen, C.J. Tack, M.H. Zaki, F.L. van de Veerdonk, and D. Perera Inflammasome is a central player in the induction of obesity and insulin resistance Proc Natl Acad Sci U S A 108 2011 15324 15329
54. C.M. Larsen, M. Faulenbach, A. Vaag, A. Volund, J.A. Ehses, and B. Seifert Interleukin-1-receptor antagonist in type 2 diabetes mellitus N Engl J Med 356 2007 1517 1526
55. J.A. Ehses, G. Lacraz, M.H. Giroix, F. Schmidlin, J. Coulaud, and N. Kassis IL-1 antagonism reduces hyperglycemia and tissue inflammation in the type 2 diabetic GK rat Proc Natl Acad Sci U S A 106 2009 13998 14003
56. M.G. Netea, L.A. Joosten, E. Lewis, D.R. Jensen, P.J. Voshol, and B.J. Kullberg Deficiency of interleukin-18 in mice leads to hyperphagia, obesity and insulin resistance Nat Med 12 2006 650 656
57. L. Gurcel, L. Abrami, S. Girardin, J. Tschopp, and F.G. van der Goot Caspase-1 activation of lipid metabolic pathways in response to bacterial pore-forming toxins promotes cell survival Cell 126 2006 1135 1145
58. W. Shao, G. Yeretssian, K. Doiron, S.N. Hussain, and M. Saleh The caspase-1 digestome identifies the glycolysis pathway as a target during infection and septic shock J Biol Chem 282 2007 36321 36329
59. J.P. Thaler, S.J. Choi, M.W. Schwartz, and B.E. Wisse Hypothalamic inflammation and energy homeostasis: resolving the paradox Front Neuroendocrinol 31 2010 79 84
60. S. Purkayastha, H. Zhang, G. Zhang, Z. Ahmed, Y. Wang, and D. Cai Neural dysregulation of peripheral insulin action and blood pressure by brain endoplasmic reticulum stress Proc Natl Acad Sci U S A 108 2011 2939 2944
61. C.N. Lumeng, and A.R. Saltiel Inflammatory links between obesity and metabolic disease J Clin Invest 121 2011 2111 2117
62. X. Zhang, G. Zhang, H. Zhang, M. Karin, H. Bai, and D. Cai Hypothalamic IKKbeta/NF-kappaB and ER stress link overnutrition to energy imbalance and obesity Cell 135 2008 61 73
63. U.K. Hanisch, T.V. Johnson, and J. Kipnis Toll-like receptors: roles in neuroprotection? Trends Neurosci 31 2008 176 182
64. A. Kleinridders, D. Schenten, A.C. Konner, B.F. Belgardt, J. Mauer, and T. Okamura MyD88 signaling in the CNS is required for development of fatty acid-induced leptin resistance and diet-induced obesity Cell Metab 10 2009 249 259
65. M. Milanski, G. Degasperi, A. Coope, J. Morari, R. Denis, and D.E. Cintra Saturated fatty acids produce an inflammatory response predominantly through the activation of TLR4 signaling in hypothalamus: implications for the pathogenesis of obesity J Neurosci 29 2009 359 370
66. T. Sartorius, S.Z. Lutz, M. Hoene, J. Waak, A. Peter, and C. Weigert Toll-like receptors 2 and 4 impair insulin-mediated brain activity by interleukin-6 and osteopontin and alter sleep architecture FASEB J 26 2012 1799 1809
67. R. Shechter, A. London, Y. Kuperman, A. Ronen, A. Rolls, and A. Chen Hypothalamic neuronal toll-like receptor 2 protects against age-induced obesity Sci Rep 3 2013 1254
68. M. Vijay-Kumar, J.D. Aitken, F.A. Carvalho, T.C. Cullender, S. Mwangi, and S. Srinivasan Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5 Science 328 2010 228 231
69. O. Osborn, H. Gram, E.P. Zorrilla, B. Conti, and T. Bartfai Insights into the roles of the inflammatory mediators IL-1, IL-18 and PGE2 in obesity and insulin resistance Swiss Med Wkly 138 2008 665 673
70. E.P. Zorrilla, M. Sanchez-Alavez, S. Sugama, M. Brennan, R. Fernandez, and T. Bartfai Interleukin-18 controls energy homeostasis by suppressing appetite and feed efficiency Proc Natl Acad Sci U S A 104 2007 11097 11102
71. M.T. Heneka, M.P. Kummer, A. Stutz, A. Delekate, S. Schwartz, and A. Vieira-Saecker NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS1 mice Nature 493 2013 674 678
72. S. Jha, S.Y. Srivastava, W.J. Brickey, H. Iocca, A. Toews, and J.P. Morrison The inflammasome sensor, NLRP3, regulates CNS inflammation and demyelination via caspase-1 and interleukin-18 J Neurosci 30 2010 15811 15820
73. M.Y. Donath, M. Boni-Schnetzler, H. Ellingsgaard, and J.A. Ehses Islet inflammation impairs the pancreatic beta-cell in type 2 diabetes Physiology (Bethesda) 24 2009 325 331
74. M.Y. Donath, and S.E. Shoelson Type 2 diabetes as an inflammatory disease Nat Rev Immunol 11 2011 98 107
75. M. Vives-Pi, N. Somoza, J. Fernandez-Alvarez, F. Vargas, P. Caro, and A. Alba Evidence of expression of endotoxin receptors CD14, toll-like receptors TLR4 and TLR2 and associated molecule MD-2 and of sensitivity to endotoxin (LPS) in islet beta cells Clin Exp Immunol 133 2003 208 218
76. K. Eguchi, I. Manabe, Y. Oishi-Tanaka, M. Ohsugi, N. Kono, and F. Ogata Saturated fatty acid and TLR signaling link beta cell dysfunction and islet inflammation Cell Metab 15 2012 518 533
77. M.Y. Donath, M. Boni-Schnetzler, H. Ellingsgaard, P.A. Halban, and J.A. Ehses Cytokine production by islets in health and diabetes: cellular origin, regulation and function Trends Endocrinol Metab 21 2010 261 267
78. S.L. Masters, A. Dunne, S.L. Subramanian, R.L. Hull, G.M. Tannahill, and F.A. Sharp Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1beta in type 2 diabetes Nat Immunol 11 2010 897 904
79. Y.H. Youm, A. Adijiang, B. Vandanmagsar, D. Burk, A. Ravussin, and V.D. Dixit Elimination of the NLRP3-ASC inflammasome protects against chronic obesity-induced pancreatic damage Endocrinology 152 2011 4039 4045
80. V.Z. Rocha, and P. Libby Obesity, inflammation, and atherosclerosis Nat Rev Cardiol 6 2009 399 409
81. G.K. Hansson, and A. Hermansson The immune system in atherosclerosis Nat Immunol 12 2011 204 212
82. A.E. Mullick, P.S. Tobias, and L.K. Curtiss Modulation of atherosclerosis in mice by Toll-like receptor 2 J Clin Invest 115 2005 3149 3156
83. M. Madan, and S. Amar Toll-like receptor-2 mediates diet and/or pathogen associated atherosclerosis: proteomic findings PLoS One 3 2008 e3204
84. A.M. Lundberg, D.F. Ketelhuth, M.E. Johansson, N. Gerdes, S. Liu, and M. Yamamoto Toll-like receptor 3 and 4 signalling through the TRIF and TRAM adaptors in hematopoietic cells promotes atherosclerosis Cardiovasc Res 2013 [Epub ahead of print]
85. K.S. Michelsen, M.H. Wong, P.K. Shah, W. Zhang, J. Yano, and T.M. Doherty Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E Proc Natl Acad Sci U S A 101 2004 10679 10684
86. Y. Ding, S. Subramanian, V.N. Montes, L. Goodspeed, S. Wang, and C. Han Toll-like receptor 4 deficiency decreases atherosclerosis but does not protect against inflammation in obese low-density lipoprotein receptor-deficient mice Arterioscler Thromb Vasc Biol 32 2012 1596 1604
87. K.R. Coenen, M.L. Gruen, R.S. Lee-Young, M.J. Puglisi, D.H. Wasserman, and A.H. Hasty Impact of macrophage toll-like receptor 4 deficiency on macrophage infiltration into adipose tissue and the artery wall in mice Diabetologia 52 2009 318 328
88. H. Bjorkbacka, V.V. Kunjathoor, K.J. Moore, S. Koehn, C.M. Ordija, and M.A. Lee Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways Nat Med 10 2004 416 421
89. W.K. den Dekker, C. Cheng, G. Pasterkamp, and H.J. Duckers Toll like receptor 4 in atherosclerosis and plaque destabilization Atherosclerosis 209 2010 314 320
90. S.L. Masters, E. Latz, and L.A. O'Neill The inflammasome in atherosclerosis and type 2 diabetes Sci Transl Med 3 2011 81ps17
91. P. Duewell, H. Kono, K.J. Rayner, C.M. Sirois, G. Vladimer, and F.G. Bauernfeind NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals Nature 464 2010 1357 1361
92. J. Gage, M. Hasu, M. Thabet, and S.C. Whitman Caspase-1 deficiency decreases atherosclerosis in apolipoprotein E-null mice Can J Cardiol 28 2012 222 229
93. F. Usui, K. Shirasuna, H. Kimura, K. Tatsumi, A. Kawashima, and T. Karasawa Critical role of caspase-1 in vascular inflammation and development of atherosclerosis in Western diet-fed apolipoprotein E-deficient mice Biochem Biophys Res Commun 425 2012 162 168
94. P. Menu, M. Pellegrin, J.F. Aubert, K. Bouzourene, A. Tardivel, and L. Mazzolai Atherosclerosis in ApoE-deficient mice progresses independently of the NLRP3 inflammasome Cell Death Dis 2 2011 e137
95. D. De Nardo, and E. Latz NLRP3 inflammasomes link inflammation and metabolic disease Trends Immunol 32 2011 373 379
96. K. Rajamaki, J. Lappalainen, K. Oorni, E. Valimaki, S. Matikainen, and P.T. Kovanen Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation PLoS One 5 2010 e11765
97. Y. Jiang, M. Wang, K. Huang, Z. Zhang, N. Shao, and Y. Zhang Oxidized low-density lipoprotein induces secretion of interleukin-1beta by macrophages via reactive oxygen species-dependent NLRP3 inflammasome activation Biochem Biophys Res Commun 425 2012 121 126
98. F. Backhed Programming of host metabolism by the gut microbiota Ann Nutr Metab 58 Suppl 2 2011 44 52
99. J.K. Nicholson, E. Holmes, J. Kinross, R. Burcelin, G. Gibson, and W. Jia Host-gut microbiota metabolic interactions Science 336 2012 1262 1267
100. P.J. Turnbaugh, R.E. Ley, M.A. Mahowald, V. Magrini, E.R. Mardis, and J.I. Gordon An obesity-associated gut microbiome with increased capacity for energy harvest Nature 444 2006 1027 1031
101. P.J. Turnbaugh, M. Hamady, T. Yatsunenko, B.L. Cantarel, A. Duncan, and R.E. Ley A core gut microbiome in obese and lean twins Nature 457 2009 480 484
102. F. Backhed, H. Ding, T. Wang, L.V. Hooper, G.Y. Koh, and A. Nagy The gut microbiota as an environmental factor that regulates fat storage Proc Natl Acad Sci U S A 101 2004 15718 15723
103. T. Greiner, and F. Backhed Effects of the gut microbiota on obesity and glucose homeostasis Trends Endocrinol Metab 22 2011 117 123
104. T. Petnicki-Ocwieja, T. Hrncir, Y.J. Liu, A. Biswas, T. Hudcovic, and H. Tlaskalova-Hogenova Nod2 is required for the regulation of commensal microbiota in the intestine Proc Natl Acad Sci U S A 106 2009 15813 15818
105. E. Elinav, T. Strowig, A.L. Kau, J. Henao-Mejia, C.A. Thaiss, and C.J. Booth NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis Cell 145 2011 745 757
106. L. Wen, R.E. Ley, P.Y. Volchkov, P.B. Stranges, L. Avanesyan, and A.C. Stonebraker Innate immunity and intestinal microbiota in the development of Type 1 diabetes Nature 455 2008 1109 1113
107. A.M. Caricilli, P.K. Picardi, L.L. de Abreu, M. Ueno, P.O. Prada, and E.R. Ropelle Gut microbiota is a key modulator of insulin resistance in TLR 2 knockout mice PLoS Biol 9 2011 e1001212
108. A. Biswas, and K.S. Kobayashi Regulation of intestinal microbiota by the NLR protein family Int Immunol 25 2013 207 214
109. N.P. Ly, A. Litonjua, D.R. Gold, and J.C. Celedon Gut microbiota, probiotics, and vitamin D: interrelated exposures influencing allergy, asthma, and obesity? J Allergy Clin Immunol 127 2011 1087 1096
110. K.M. Maslowski, and C.R. Mackay Diet, gut microbiota and immune responses Nat Immunol 12 2011 5 9
111. T. Nakamura, M. Furuhashi, P. Li, H. Cao, G. Tuncman, and N. Sonenberg Double-stranded RNA-dependent protein kinase links pathogen sensing with stress and metabolic homeostasis Cell 140 2010 338 348